Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report)’s share price dropped 0.4% during mid-day trading on Tuesday . The company traded as low as $1.80 and last traded at $1.81. Approximately 2,175 shares traded hands during trading, a decline of 87% from the average daily volume of 16,658 shares. The stock had previously closed at $1.81.
Medexus Pharmaceuticals Price Performance
The company’s fifty day simple moving average is $1.59 and its 200 day simple moving average is $1.36.
About Medexus Pharmaceuticals
Medexus Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada and the United States. The company focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. Its primary products are IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; and Gleolan, an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery.
Further Reading
- Five stocks we like better than Medexus Pharmaceuticals
- What Are Dividend Champions? How to Invest in the Champions
- Study: How Much Are Retirees Earning from Side Hustles in 2024?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Brinker International Offers a Pullback Opportunity on EPS Miss
- What is Insider Trading? What You Can Learn from Insider Trading
- Globant Is an Emerging AI Play That’s Expanding Its Footprint
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
